Advertisement

Topics

Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results

07:00 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Conference Call and Webcast Today, February 28, at 8:00 a.m. ET – Ophthotech Corporation (Nasdaq:OPHT) today announced financial and operating results for the fourth quarter and full year ended December 31, 2016 and prov...

Other Sources for this Article

Investors
Ophthotech Corporation
Kathy Galante, 212-845-8231
Vice President, Investor Relations and Corporate Communications
kathy.galante@ophthotech.com
or
Media
SmithSolve LLC on behalf of Ophthotech Corporation
Alex Van Rees, 973-442-1555 ext. 111
alex.vanrees@smithsolve.com

NEXT ARTICLE

More From BioPortfolio on "Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...